Adherence to treatment guidelines in two primary care populations with gout

Rheumatology International

Volumn 30, Issue 6, 2010, Pages 749-753

  Wall, Geoffrey C ^a,b   Koenigsfeld, Carrie F ^a,c   Hegge, Karly A ^d   Bottenberg, Michelle M ^a,e  

^a DRAKE UNIVERSITY   (United States)

^b IOWA METHODIST MEDICAL CENTER   (United States)

^c Lakeview Internal Medicine Clinic   (United States)

^d SOUTH DAKOTA STATE UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gout; Guidelines; Primary Care; Treatment

Indexed keywords

ALLOPURINOL; NICOTINIC ACID; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; FEMALE; GOUT; HUMAN; HYPERURICEMIA; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; URIC ACID NEPHROPATHY;

AGED; AMBULATORY CARE FACILITIES; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GOUT; GUIDELINE ADHERENCE; HUMANS; INTERNAL MEDICINE; MALE; MONITORING, PHYSIOLOGIC; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF HEALTH CARE; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; URIC ACID;

EID: 77951022954     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1056-7     Document Type: Article

References (12)

1. Terkeltaub RA (2003) Gout. N Engl J Med 349:1647-1655. doi:10.1056/NEJMcp030733 (Pubitemid 37303887)
2. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403-2406
3. Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, Bilker WB, Saag KG (2004) Quality of care indicators for gout management. Arthritis Rheum 50:937-943. doi:10.1002/art.20102 (Pubitemid 38326194)
4. Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301-1311. doi:10.1136/ard.2006.055251 (Pubitemid 44641591)
5. Zhang W, Doherty M, Bardin T et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312-1324. doi:10.1136/ard.2006.055269 (Pubitemid 44620440)
6. Sarawate CA, Brewer KK, Yang W et al (2006) Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 81:925-934. doi:10.4065/ 81.7.925
7. Pal B, Foxall M, Dysart T, Carey F, Whittaker M (2000) How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol 19:21-25. doi:10.1007/ s100670050005 (Pubitemid 30123236)
8. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG (2005) Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) 44:1038-1042. doi:10.1093/rheumatology/ keh679
9. Sarawate CA, Patel PA, Schumacher HR et al (2006) Serum urate levels and gout Xares: analysis from managed care data. J Clin Rheumatol 12:61-65. doi:10.1097/01.rhu.0000209882.50228.9f (Pubitemid 44309598)
10. Hanly JG, Skedgel C, Sketris I et al (2009) Gout in the elderly-a population health study. J Rheumatol 36:822-830. doi:10.3899/ jrheum.080768
11. Siegel D, Lopez J, Meier J, Goldstein MK, Lee S, Brazill BJ, Matalka MS (2003) Academic detailing to improve antihypertensive prescribing patterns. Am J Hypertens 16:508-511. doi:10.1016/ S0895-7061(03)00060-68
12. Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, SchaiV R, Kessels A, Braverman A, Goldberg A, Waterman B, Dunagan WC (2007) An intervention to improve secondary prevention of coronary heart disease. Arch Intern Med 167:586-590. doi:10.1001/ archinte.167.6.586